Andrews Julie 4

What Happened Julie Andrews, an outside director of RxSight, Inc. (RXST), was granted 37,037 restricted stock units (RSUs) on June 17, 2026. The filing lists this as an award (Form 4 transaction code A); no per-share price or immediate cash value is reported (price: N/A). These RSUs are a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: June 17, 2026; Form 4 filed June 18, 2026 (timely).
• Security: 37,037 RSUs (each RSU represents a contingent right to one share of common stock).
• Price/Value: N/A in the filing (RSUs valued based on company share price when they vest or are settled).
• Vesting: 100% of the RSUs vest on the earlier of (i) the one-year anniversary of the grant (June 17, 2027) or (ii) the date of the next annual meeting of stockholders, provided the reporting person continues as an Outside Director.
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Filing remarks: Exhibit 24 — Power of Attorney included.
• Transaction code: A = Award/Grant of equity.

Context RSU grants to directors are common compensation to align their interests with shareholders. These RSUs do not convert to actual shares until they vest and are typically subject to continued service requirements; they are not an immediate market purchase that signals a direct personal investment. There is no indication of a sale, option exercise, tax withholding, or 10b5-1 plan in this filing.